CareDx CDNA
NASDAQ CDNA
$53.83 -0.45 (-0.83%)
At close: Sep 18, 2026 · 4:00 PM EDT

CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2023)

CareDx's (CDNA) quarterly Asset Writedowns and Impairment came in at $1.0 million in Q1 2023, up 19.05% quarter-over-quarter from $840000.0 in Q3 2022.

Analysis

CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2023) Analysis & Trends

CareDx has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $1.0 million for Q1 2023.

  • In Q1 2023, Asset Writedowns and Impairment changed N/A year-over-year to $1.0 million; the TTM figure through Dec 2023 stood at $1.0 million (up 19.05% YoY), while the FY2025 annual figure was $2.3 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment came in at $1.0 million for Q1 2023 at CareDx, up from $840000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.4 million in Q4 2021 to a low of $840000.0 in Q3 2022.
  • Average Asset Writedowns and Impairment over 3 years is $1.4 million, with a median of $1.0 million recorded in 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 CareDx 2.77 Bn 2.40 Bn 116.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1.00 Mn
Sep 30, 2022 840,000.00
Dec 31, 2021 2.44 Mn